PKM2 is unique because it can exist in both an active tetrameric form and a less active dimeric form. The dimeric form of PKM2 allows for the accumulation of glycolytic intermediates, which are diverted into anabolic pathways to support rapid cell growth and proliferation. This characteristic makes PKM2 a key player in tumor metabolism and an attractive target for cancer therapy.
